Cited by 1,066DNA Repair MechanismsFungal and yeast genetics researchGenomics and Chromatin Dynamics

Regulation of Homologous Recombination in Eukaryotes

Open access
Heyer, Wolf-Dietrich, Ehmsen, Kirk T., Liu, Jie·2010·Annual Review of Genetics

Abstract

Homologous recombination (HR) is required for accurate chromosome segregation during the first meiotic division and constitutes a key repair and tolerance pathway for complex DNA damage, including DNA double-strand breaks, interstrand crosslinks, and DNA gaps. In addition, recombination and replication are inextricably linked, as recombination recovers stalled and broken replication forks, enabling the evolution of larger genomes/replicons. Defects in recombination lead to genomic instability and elevated cancer predisposition, demonstrating a clear cellular need for recombination. However, recombination can also lead to genome rearrangements. Unrestrained recombination causes undesired endpoints (translocation, deletion, inversion) and the accumulation of toxic recombination intermediates. Evidently, HR must be carefully regulated to match specific cellular needs. Here, we review the factors and mechanistic stages of recombination that are subject to regulation and suggest that recombination achieves flexibility and robustness by proceeding through metastable, reversible intermediates.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1146/annurev-genet-051710-150955

Cites

177 of 177 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cell cycle phase dominates the choice between NHEJ and HDR, with HDR taking place mainly in S and G2 phases due to the availability of sister chromatids as templates.

    “Cell cycle phase dominates the choice between NHEJ and HDR, with HDR taking place mainly in S and G2 phases due to the availability of sister chromatids as templates.61”

    From CRISPR-Cas9: a new and promising player in gene therapy (2015) · cites this paper as [61]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [103]Morris JR Boutell C Keppler M Densham R Weekes D 2009 The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress Nature 462 886 90 20016594
  2. [106]Murray AW Hunt T 1993 The Cell Cycle New York, Oxford Oxford University Press
  3. [150]Torres-Rosell J Sunjevaric I De Piccoli G Sacher M Eckert-Boulet N 2007 The Smc5-Smc6 complex and SUMO modification of Rad52 regulates recombinational repair at the ribosomal gene locus Nat Cell Biol 9 923 31 17643116

Cited by

Sorted by citations

Authors
Heyer, W.-D., Ehmsen, K. T., & Liu, J.
Affiliations
University of California, Davis (US)
Venue
Annual Review of Genetics
Published
2010-12-01
Volume
44
Issue
1
Pages
113-139
ISSN
  • 0066-4197 (ISSN-L)
  • 1545-2948
OpenAlex
W2109879947
Cited by
1,066
References
177
Citations by year
2026: 26 · 2025: 44 · 2024: 54 · 2023: 64 · 2022: 70 · 2021: 91 · 2020: 86 · 2019: 75 · 2018: 79 · 2017: 86 · 2016: 83 · 2015: 71 · 2014: 67 · 2013: 67 · 2012: 62
FWCI
4.67
Type
journal article
Language
en
Open access
Locations
  • Annual Review of Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Tobacco-Related Disease Research Program
  • National Institutes of Health
  • National Cancer Institute (CA92776, R01CA092276, R03CA092776)
  • National Institute of General Medical Sciences (GM58015, R01GM058015)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
homologous recombination, recombination regulation, DNA double-strand breaks, meiotic chromosome segregation, DNA repair, DNA damage tolerance, replication fork recovery, genomic instability, cancer susceptibility, genome rearrangement, translocation, recombination intermediates, metastable intermediates, eukaryotic cells
MeSH terms
Animals, DNA Repair, Humans, Recombination, Genetic, Yeasts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review